First Time Loading...
A

Andlauer Healthcare Group Inc
TSX:AND

Watchlist Manager
Andlauer Healthcare Group Inc
TSX:AND
Watchlist
Price: 42.43 CAD 0.78%
Updated: May 2, 2024
Section:
 

Relative Value

The Relative Value of one AND stock under the Base Case scenario is 59.23 CAD. Compared to the current market price of 42.43 CAD, Andlauer Healthcare Group Inc is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AND Relative Value
Base Case
59.23 CAD
Undervaluation 28%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

2.7
P/S
P/S
Price to Sales
2.7
vs History
80
vs Industry
42
Median 3Y
3.6
Median 5Y
3.7
Industry
2.4
Forward
2.5
More Details
26.6
P/E
P/E
Price to Earnings
26.6
vs History
49
vs Industry
22
Median 3Y
25.3
Median 5Y
26.4
Industry
23.2
Forward
22.6
More Details
16.8
P/OCF
P/OCF
Price to OCF
16.8
vs History
56
vs Industry
25
Median 3Y
17.1
Median 5Y
18
Industry
15.5
More Details
68
P/FCFE
P/FCFE
Price to FCFE
68
vs History
10
vs Industry
8
Median 3Y
35
Median 5Y
27.6
Industry
23.5
More Details
3.7
P/B
P/B
Price to Book Value
3.7
vs History
83
vs Industry
24
Median 3Y
5
Median 5Y
5.5
Industry
2.2
More Details
2.8
EV/S
EV/S
Enterprise Value to Sales
2.8
vs History
81
vs Industry
41
Median 3Y
3.7
Median 5Y
3.8
Industry
2.5
Forward
2.6
More Details
5.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
5.6
vs History
76
vs Industry
41
Median 3Y
7.3
Median 5Y
7.4
Industry
5.2
More Details
10.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.9
vs History
80
vs Industry
31
Median 3Y
13.8
Median 5Y
14.9
Industry
12.5
Forward
10.1
More Details
18.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
18.6
vs History
74
vs Industry
26
Median 3Y
22
Median 5Y
23.4
Industry
17.2
Forward
16.8
More Details
17.1
EV/OCF
EV/OCF
Enterprise Value to OCF
17.1
vs History
58
vs Industry
26
Median 3Y
17.7
Median 5Y
19.1
Industry
15.1
More Details
22.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
22.7
vs History
47
vs Industry
22
Median 3Y
22.2
Median 5Y
22.3
Industry
19.7
More Details
3.1
EV/IC
EV/IC
Enterprise Value to IC
3.1
vs History
81
vs Industry
27
Median 3Y
3.5
Median 5Y
3.7
Industry
2
More Details

Multiples Across Competitors

AND Competitors Multiples
Andlauer Healthcare Group Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Andlauer Healthcare Group Inc
TSX:AND
1.8B CAD 2.7 26.6 10.9 18.6
US
Cigna Group
XMUN:CGN
97.2B EUR 0.5 20.1 10.3 13.8
US
Cigna Corp
NYSE:CI
102.4B USD 0.5 19.8 10.2 13.6
US
CVS Health Corp
NYSE:CVS
70B USD 0.2 8.4 7.7 7.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR 0.7 -26.6 10.1 22.6
US
Laboratory Corporation of America Holdings
NYSE:LH
16.8B USD 1.4 38.9 11.9 17.9
US
Quest Diagnostics Inc
NYSE:DGX
15B USD 1.6 17.9 10.7 14.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.8B EUR 0.6 23.7 7 16.5
US
DaVita Inc
NYSE:DVA
12.5B USD 1 18.1 8.7 12.8
DE
Fresenius Medical Care AG
XMUN:FME
11.4B EUR 0.6 22.8 6.8 16.2
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
AND intrinsic value, competitors valuation, and company profile.
DCF Valuation
AND stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AND stock valuation using valuation multiples.
Wall Street Estimates
AND price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AND stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.